MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Effect of H. pylori Infection on L-DOPA Pharmacokinetics in Patients with Parkinson’s disease.

S. Oda, Y. Saitoh, J. Takei, S. Watanabe, Y. Mukai, Y. Takahashi (Kodaira, Japan)
Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson’s Disease

M. Beke, P. Mackie, C. Rusch, E. Klann, A. Gurrala, S. Chua, E. Ince, L. Almeida, A. Ramirez-Zamora (Gainesville, USA)
Effect of oxytocin on response inhibition in Parkinson´s disease: a pilot study

F. Carbone, P. Ellmerer, S. Spielberger, M. Peball, V. Sidoroff, M. Ritter, K. Seppi, W. Poewe, A. Djamshidian (Innsbruck, Austria)
Effect of physical exercises on gait speed in patients with Parkinson’s disease

D. Bueno, L. Oliveira, L. Ota, P. Polidoro, G. da Costa (Dracena, Brazil)
Effect of probiotics on MDS UPDRS in Parkinson disease at 12 weeks: A Randomized double-blind placebo-controlled trial

G. George, T. Iype (Thiruvananthapuram, India)
Effect of simultaneous mGlu2 positive allosteric modulation and orthosteric stimulation combined with 5-HT2A antagonism on psychosis-like behaviours, dyskinesia and parkinsonism in the MPTP-lesioned marmoset

S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)
Effect of the GlyT1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset

I. Frouni, SG. Nuara, D. Bédard, A. Hamadjida, JC. Gourdon, P. Huot (Montreal, Canada)
Effect of the mGlu2/3 orthosteric agonist LY-404,039 on abnormal involuntary movements and parkinsonism in the 6-OHDA-lesioned rat

W. Kang, I. Frouni, C. Kwan, L. Desbiens, D. Bédard, A. Hamadjida, P. Huot (Montreal, Canada)
EFFECT OF TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) ON LOCOMOTOR FUNCTION IN PATIENTS WITH PARKINSON’S DISEASE

M. Shah, B. Bajaj, I. Ali (New Delhi, India)
Effect of Venglustat by GBA Mutation Severity in Patients With Parkinson’s Disease

J. Peterschmitt, N. Giladi, R. Alcalay, G. Cutter, G. Höglinger, A. Schapira, C. Scherzer, T. Simuni, T. Gurevich, T. Gasser, C. Pacchetti, K. Marek, P. Minini, S. Sardi (Cambridge, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z